|
|
Articles
by
Matthew Baumgart |
Total Records (
2 ) for
Matthew Baumgart |
|
 |
|
|
|
Kyra Rosow
,
Andrew Holzapfel
,
Jason H. Karlawish
,
Matthew Baumgart
,
Lisa J. Bain
and
Ara S. Khachaturian
|
|
As the worlds population ages, countries must prepare for the significant impact Alzheimers disease will have on their health systems, their economies, and their citizens. In anticipation of major global demographic changes, many countries in the G-20 since 2000 have begun to develop and enact plans to address Alzheimes disease as a national priority. However, even with nearly half of these participating countries having plans in place, there has been little research done to quantify the value of enacting a countrywide plan on this disease. In this review, we summarize recent national plans (from the year 2000 and beyond) and any results stemming from their respective recommendations and activities. |
|
|
|
|
Mary D. Naylor
,
Jason H. Karlawish
,
Steven E. Arnold
,
Ara S. Khachaturian
,
Zaven S. Khachaturian
,
Virginia M.-Y. Lee
,
Matthew Baumgart
,
Sube Banerjee
,
Cornelia Beck
,
Kaj Blennow
,
Ron Brookmeyer
,
Kurt R. Brunden
,
Kathleen C. Buckwalter
,
Meryl Comer
,
Kenneth Covinsky
,
Lynn Friss Feinberg
,
Giovanni Frisoni
,
Colin Green
,
Renato Maia Guimaraes
,
Lisa P. Gwyther
,
Franz F. Hefti
,
Michael Hutton
,
Claudia Kawas
,
David M. Kent
,
Lewis Kuller
,
Kenneth M. Langa
,
Robert W. Mahley
,
Katie Maslow
,
Colin L. Masters
,
Diane E. Meier
,
Peter J. Neumann
,
Steven M. Paul
,
Ronald C. Petersen
,
Mark A. Sager
,
Mary Sano
,
Dale Schenk
,
Holly Soares
,
Reisa A. Sperling
,
Sidney M. Stahl
,
Vivianna van Deerlin
,
Yaakov Stern
,
David Weir
,
David A. Wolk
and
John Q. Trojanowski
|
|
To address the pending public health crisis due to Alzheimers disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled "State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care," on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article. |
|
|
|
|
|
|